Extracorporeal Blood Purification Therapies for Prevention of Radiocontrast-Induced Nephropathy: A Systematic Review

American Journal of Kidney Diseases

Volumn 48, Issue 3, 2006, Pages 361-371

  Cruz, Dinna N ^a   Perazella, Mark A ^a   Bellomo, Rinaldo ^a   Corradi, Valentina ^a   de Cal, Massimo ^a   Kuang, Dingwei ^a   Ocampo, Catalina ^a   Nalesso, Federico ^a   Ronco, Claudio ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Continuous renal replacement therapy; hemodialysis (HD); hemofiltration; meta analysis; prevention; radiocontrast nephropathy

Indexed keywords

ACETYLCYSTEINE; AMINOPHYLLINE; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN;

BIBLIOGRAPHIC DATABASE; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DATA BASE; EMBASE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INCIDENCE; KIDNEY DISEASE; LITERATURE; MEDLINE; RANDOMIZATION; REVIEW; SAMPLE SIZE; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

CONTRAST MEDIA; HEMOFILTRATION; HUMANS; KIDNEY DISEASES; RANDOMIZED CONTROLLED TRIALS; RENAL DIALYSIS;

EID: 33747595435     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.05.023     Document Type: Review

References (40)

1. Nash K., Hafeez A., and Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 39 (2002) 930-936
2. McCullough P.A., and Sandberg K.R. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 4 suppl 5 (2003) S3-S9
3. Lasser E., Lyon S.G., and Berry C. Reports on contrast media reactions. Analysis of data from reports to the US Food and Drug Administration. Radiology 203 (1997) 605-610
4. Conti C.R. Cardiovascular happenings in Europe. Clin Cardiol 23 (2000) 471-472
5. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
6. Moreau J.F., Noel L.H., and Droz D. Proximal renal tubular vacuolization induced by iodinated contrast media, or so-called 'osmotic nephrosis.'. Invest Radiol 28 (1993) 187-190
7. Bakris G.L., Lass N., Gaber A.O., Jones J.D., and Burnett J.C. Radiocontrast medium-induced declines in renal function. A role for oxygen-free radicals. Am J Physiol 258 (1990) F115-F120
8. Asif A., and Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 44 (2004) 12-24
9. McCullough P.A., and Soman S.S. Contrast-induced nephropathy. Crit Care Clin 21 (2005) 261-280
10. Alonso A., Lau J., Jaber B.L., Weintraub A., and Sarnak M.J. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease. A meta-analysis of randomized controlled trials. Am J Kidney Dis 43 (2004) 1-9
11. Ix J.H., McCulloch C.E., and Chertow G.M. Theophylline for the prevention of radiocontrast nephropathy. A meta-analysis. Nephrol Dial Transplant 19 (2004) 2747-2753
12. Schindler R., Stahl C., Venz S., Ludat K., Krause W., and Frei U. Removal of contrast media by different extracorporeal treatments. Nephrol Dial Transplant 16 (2001) 1471-1474
13. Gabutti L., Marone C., Monti M., et al. Does continuous venovenous hemodiafiltration concomitant with radiological procedures provide a significant and safe removal of the iodinated contrast ioversol?. Blood Purif 21 (2003) 152-157
14. Acute Dialysis Quality Initiative (ADQI): ADQI Documents, ADQI 3 Overview. Available at: www.adqi.net. Accessed March 13, 2006.
15. Gottlieb S.S., Abraham W., Butler J., et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8 (2002) 136-141
16. Kjaergard L.L., Villumsen J., Gluud C., et al. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135 (2001) 982-989
17. Berger E., Bader B., Bosker J., Risler T., and Erley C. Contrast media-induced kidney failure cannot be prevented by hemodialysis. Dtsch Med Wochenschr 126 (2001) 162-166
18. Frank H., Werner D., Lorusso V., et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 60 (2003) 176-182
19. Hsieh Y.C., Ting C.T., Liu T.J., Wang C.L., Chen Y.T., and Lee W.L. Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency. Int J Cardiol 101 (2005) 407-413
20. Lehnert T., Keller E., Gondolf K., Schaffner T., Pavenstadt H., and Schollmeyer P. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 13 (1998) 358-362
21. Sterner G., Frennby B., Kurkus J., and Nyman U. Does post-angiographic hemodialysis reduce the risk of contrast-medium nephropathy?. Scand J Urol Nephrol 34 (2000) 323-326
22. Vogt B., Ferrari P., Schonholzer C., et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111 (2001) 692-698
23. Huber W., Jeschke B., Kreymann B., et al. Haemodialysis for the prevention of contrast-induced nephropathy. Invest Radiol 37 (2002) 471-481
24. Schaffner T., Gondolf K., Lehnert T., and Keller E. Nephrotoxicity of radio-contrast agents. Nieren-und Hochdruckkrankheiten 26 (1997) 283-291
25. Ferrari P., and Vogt B. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med 350 (2004) 837-838 (letter)
26. Marenzi G., Marana I., Lauri G., et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349 (2003) 1333-1340
27. Marenzi G., and Bartorelli A.L. Hemofiltration in the prevention of radiocontrast nephropathy. Minerva Anestesiol 70 (2004) 189-191
28. Marenzi G., Bartorelli A.L., Lauri G., et al. Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions. Catheter Cardiovasc Interv 58 (2003) 59-64
29. Marenzi G., Lauri G., Campodonico J., et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 119 (2006) 155-162
30. Rickli H., Benou K., Ammann P., et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 61 (2004) 98-102
31. Han W.K., Bailly V., Abichandani R., Thadhani R., and Bonventre J.V. Kidney injury molecule-1 (KIM-1). A novel biomarker for human renal proximal tubule injury. Kidney Int 62 (2002) 237-244
32. Muramatsu Y., Tsujie M., Kohda Y., et al. Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury. Kidney Int 62 (2002) 1601-1610
33. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 (2005) 1231-1238
34. Manns B.J., Taub K.J., and Donaldson C. Economic evaluation and end-stage renal disease. From basics to bedside. Am J Kidney Dis 36 (2000) 12-28
35. Russo D., Minutolo R., Cianciaruso B., Memoli B., Conte G., and De Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6 (1995) 1451-1458
36. Ronco C., Bellomo R., Homel P., et al. Effects of different doses in continuous venovenous hemofiltration on outcomes of acute renal failure. Lancet 356 (2000) 20-30
37. Sela S., Shurtz-Swirski R., Shapiro G., et al. Oxidative stress during hemodialysis. Effect of heparin. Kidney Int Suppl 78 (2001) S159-S163
38. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA 291 (2004) 2328-2334
39. Forman J. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. N Engl J Med 350 (2004) 837 (letter)
40. Smith G.L., Vaccarino V., Kosiborod M., et al. Worsening renal function. What is a clinically meaningful change in creatinine during hospitalization with heart failure?. J Card Fail 9 (2003) 13-25